NewEdge Wealth LLC acquired a new stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 3,235 shares of the insurance provider’s stock, valued at approximately $770,000.
Other institutional investors have also recently added to or reduced their stakes in the company. MV Capital Management Inc. purchased a new position in Allstate in the fourth quarter valued at approximately $25,000. Gables Capital Management Inc. purchased a new stake in Allstate during the 2nd quarter worth $26,000. Navalign LLC purchased a new position in Allstate in the fourth quarter valued at about $27,000. Kelleher Financial Advisors purchased a new position in Allstate in the second quarter valued at about $28,000. Finally, Evolution Wealth Management Inc. lifted its stake in shares of Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 140 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Activity
In other news, Director Andrea Redmond sold 2,225 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $202.91, for a total transaction of $451,474.75. Following the sale, the director directly owned 2,225 shares in the company, valued at approximately $451,474.75. This represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the transaction, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This represents a 40.61% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 91,446 shares of company stock valued at $24,208,675. 1.55% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on Allstate
More Allstate News
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
- Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
- Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
- Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
- Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
- Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates
Allstate Stock Performance
Allstate stock opened at $253.82 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22. The company has a fifty day moving average price of $250.34 and a two-hundred day moving average price of $224.95. The company has a market cap of $64.18 billion, a PE ratio of 5.07, a P/E/G ratio of 0.39 and a beta of 0.16.
Allstate (NYSE:ALL – Get Free Report) last issued its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The company had revenue of $18.60 billion for the quarter, compared to analysts’ expectations of $15.46 billion. During the same period in the prior year, the company earned $5.94 earnings per share. The firm’s revenue was up 11.8% compared to the same quarter last year. Research analysts expect that The Allstate Corporation will post 34.45 earnings per share for the current year.
Allstate Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Monday, August 31st. Allstate’s payout ratio is presently 8.63%.
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading
- Five stocks we like better than Allstate
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
